Biotech · Private company
ABLi Therapeutics, Inc.
Track this companyFree. Adds ABLi Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- IkT-148009 (risvodetinib)Phase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 100mg IkT-148009 DryPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- 100mg IkT-148009 WetPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- 200 mg ItraconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- 200mg of Ikt-148009Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- 50mg IkT-148009 WetPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- IkT-148009Phase 1 · Healthy ElderlyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A PK Study of IkT-148009 in Older and Elderly Healthy SubjectsPHASE1 · COMPLETED · started Jun 21, 2023ClinicalTrials.gov NCT06644326 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's DiseasePHASE2 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05424276 · fetched Nov 12, 2026
- A Phase I Dosing Study of IkT-148009.PHASE1 · COMPLETED · started Feb 21, 2023ClinicalTrials.gov NCT06641557 · fetched Nov 12, 2026
- A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's PatientsPHASE1 · COMPLETED · started Feb 16, 2021ClinicalTrials.gov NCT04350177 · fetched Nov 12, 2026